SUSQUEHANNA INTERNATIONAL GROUP, LLP - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 50 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$130,172
-22.5%
166,888
-8.1%
0.00%
Q2 2023$167,980
+309.1%
181,600
+545.7%
0.00%
Q4 2022$41,064
-86.0%
28,126
-83.7%
0.00%
Q2 2022$293,000
-27.7%
172,312
-12.4%
0.00%
Q1 2022$405,000
-72.2%
196,807
-49.3%
0.00%
Q4 2021$1,456,000
-33.2%
388,376
-7.9%
0.00%
Q3 2021$2,181,000
+123.0%
421,914
+83.8%
0.00%
Q2 2021$978,000
-39.4%
229,610
-24.4%
0.00%
Q1 2021$1,613,000
-63.5%
303,744
-63.0%
0.00%
Q4 2020$4,422,000
+102.3%
821,002
+199.7%
0.00%
Q3 2020$2,186,000
-50.9%
273,900
-38.5%
0.00%
-100.0%
Q2 2020$4,455,000
+33.1%
445,100
+80.4%
0.00%
Q3 2018$3,346,000
+157.6%
246,763
+125.4%
0.00%
Q2 2018$1,299,000
-40.1%
109,500
-43.3%
0.00%
Q1 2018$2,168,000
+715.0%
193,105
+385.2%
0.00%
Q4 2017$266,000
+212.9%
39,800
+282.7%
0.00%
Q3 2017$85,000
+30.8%
10,400
-34.8%
0.00%
Q4 2016$65,000
-50.4%
15,941
+47.0%
0.00%
Q4 2015$131,00010,8440.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q1 2017
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 1,377,294$1,501,2502.44%
NEA Management Company, LLC 17,079,779$18,616,9581.29%
Endurant Capital Management LP 1,660,835$1,810,3100.93%
Matrix Capital Management Company, LP 38,974,185$42,481,8620.58%
Long Focus Capital Management, LLC 5,435,439$5,924,6290.34%
PFM Health Sciences, LP 5,992,571$6,531,9020.29%
Key Client Fiduciary Advisors, LLC 321,155$350,0590.22%
DAFNA Capital Management LLC 351,064$382,6600.12%
Rock Springs Capital Management LP 2,787,845$3,038,7510.07%
Baker Brothers Advisors 9,830,877$10,715,6560.06%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders